Cargando…

Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis

BACKGROUND: The number of patients treated with extracorporeal membrane oxygenation (ECMO) devices is increasing. Anticoagulation therapy is crucial to prevent thrombosis during ECMO therapy. Predominantly, heparin has been used as primary anticoagulant but direct thrombin inhibitors (DTI) have been...

Descripción completa

Detalles Bibliográficos
Autores principales:	M’Pembele, René, Roth, Sebastian, Metzger, Aljoscha, Nucaro, Anthony, Stroda, Alexandra, Polzin, Amin, Hollmann, Markus W., Lurati Buse, Giovanna, Huhn, Ragnar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330661/ https://www.ncbi.nlm.nih.gov/pubmed/35902857 http://dx.doi.org/10.1186/s12959-022-00401-2

Ejemplares similares

Fibrinogen–Albumin-Ratio is an independent predictor of thromboembolic complications in patients undergoing VA-ECMO
por: Roth, Sebastian, et al.
Publicado: (2021)

Neutrophil-lymphoycyte-ratio, platelet-lymphocyte-ratio and procalcitonin for early assessment of prognosis in patients undergoing VA-ECMO
por: Roth, Sebastian, et al.
Publicado: (2022)

Risk Factors for Acute Kidney Injury Requiring Renal Replacement Therapy after Orthotopic Heart Transplantation in Patients with Preserved Renal Function
por: M‘Pembele, René, et al.
Publicado: (2021)

Life impact of VA‐ECMO due to primary graft dysfunction in patients after orthotopic heart transplantation
por: M'Pembele, René, et al.
Publicado: (2021)

Noninvasive evaluation of the hemodynamic status in patients after heart transplantation or left ventricular assist device implantation
por: Roth, Sebastian, et al.
Publicado: (2022)

Postoperative high-sensitivity troponin T predicts 1-year mortality and days alive and out of hospital after orthotopic heart transplantation
por: M’Pembele, René, et al.
Publicado: (2023)

Impact of Cardiopulmonary Resuscitation of Donors on Days Alive and Out of Hospital after Orthotopic Heart Transplantation
por: Roth, Sebastian, et al.
Publicado: (2022)

Days alive and out of hospital after left ventricular assist device implantation
por: Roth, Sebastian, et al.
Publicado: (2022)

Incidence and prognosis of myocardial injury in patients with severe trauma
por: Stroda, Alexandra, et al.
Publicado: (2021)

Association between hypotension and myocardial injury in patients with severe trauma
por: Stroda, Alexandra, et al.
Publicado: (2022)

Validation of days alive and out of hospital as a new patient-centered outcome to quantify life impact after heart transplantation
por: M’Pembele, René, et al.
Publicado: (2022)

Myocardial Injury Is Associated with the Incidence of Major Adverse Cardiac Events in Patients with Severe Trauma
por: Stroda, Alexandra, et al.
Publicado: (2022)

Influence of Short and Long Hyperglycemia on Cardioprotection by Remote Ischemic Preconditioning—A Translational Approach
por: Feige, Katharina, et al.
Publicado: (2022)

Impact of Left Ventricular Assist Devices on Days Alive and Out of Hospital in Hemodynamically Stable Patients with End-Stage Heart Failure: A Propensity Score Matched Study
por: Tenge, Theresa, et al.
Publicado: (2022)

Perioperative Kardioprotektion – „From bench to bedside“: Aktuelle experimentelle Evidenz und mögliche Gründe für die limitierte Translation in die klinische Praxis
por: Torregroza, Carolin, et al.
Publicado: (2021)

Cardioprotective Properties of Humoral Factors Released after Remote Ischemic Preconditioning in CABG Patients with Propofol-Free Anesthesia—A Translational Approach from Bedside to Bench
por: Feige, Katharina, et al.
Publicado: (2022)

European NSTEMI guidelines—return of clopidogrel?
por: Dannenberg, Lisa, et al.
Publicado: (2021)

Bilirubin—A Possible Prognostic Mortality Marker for Patients with ECLS
por: Bunte, Sebastian, et al.
Publicado: (2020)

Staphylococcus aureus increases platelet reactivity in patients with infective endocarditis
por: Polzin, Amin, et al.
Publicado: (2022)

Anticoagulation with direct thrombin inhibitors during extracorporeal membrane oxygenation
por: Burstein, Barry, et al.
Publicado: (2019)

Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study
por: Cartwright, Bruce, et al.
Publicado: (2021)

Heparin-like effect in postcardiotomy extracorporeal membrane oxygenation patients
por: Ranucci, Marco, et al.
Publicado: (2014)

Extracorporeal Membrane Oxygenation Complications in Heparin- and Bivalirudin-Treated Patients
por: Giuliano, Katherine, et al.
Publicado: (2021)

The Changing Landscape of Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation: Use of the Direct Thrombin Inhibitors
por: Neunert, Cindy, et al.
Publicado: (2022)

Heparin-Induced Thrombocytopenia in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation
por: Lüsebrink, Enzo, et al.
Publicado: (2023)

Thrombin Decrease in Thrombin Generation after Heparin Administration in a Homozygous Type II Heparin-Binding Site Antithrombin-Deficient Pregnant Woman
por: Malíková, Ivana, et al.
Publicado: (2023)

Risk prediction of bleeding and MACCE by PRECISE-DAPT score post-PCI
por: Dannenberg, Lisa, et al.
Publicado: (2021)

Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation
por: Ranucci, Marco, et al.
Publicado: (2011)

Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation
por: Lubnow, Matthias, et al.
Publicado: (2022)

The Melatonin Receptor Agonist Ramelteon Induces Cardioprotection that Requires MT2 Receptor Activation and Release of Reactive Oxygen Species
por: Stroethoff, Martin, et al.
Publicado: (2020)

Pharmacological Conditioning of the Heart: An Update on Experimental Developments and Clinical Implications
por: Roth, Sebastian, et al.
Publicado: (2021)

Validation of high concentrated thrombin time assay for unfractionated heparin monitoring
por: Apipongrat, Dollapak, et al.
Publicado: (2022)

Heparin-free extracorporeal membrane oxygenation in a patient with severe pulmonary contusions and bronchial disruption
por: Ryu, Kyoung Min, et al.
Publicado: (2018)

Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study
por: Fisser, Christoph, et al.
Publicado: (2021)

Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Using anti-platelet therapy to prevent extracorporeal membrane oxygenator thrombosis without heparin resistance and with thrombocytopenia
por: He, Huai-Wu, et al.
Publicado: (2014)

Superiority of bivalirudin over heparin anticoagulation therapy for extracorporeal membrane oxygenation? Too early to draw conclusions
por: Gu, Jie, et al.
Publicado: (2023)

Heparin-free veno-venous extracorporeal membrane oxygenation in non-trauma patients with difficult airways for surgery
por: Chen, Hongya, et al.
Publicado: (2023)

Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review
por: Valdes, Carlos A., et al.
Publicado: (2023)

Effect of a Direct Thrombin Inhibitor Compared with Dalteparin and Unfractionated Heparin on Human Osteoblasts
por: Winkler, Tobias, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lbheld7vkn35e5tfkj8efi8ejr